High materiality7/10
BMO Capital Reiterates Outperform Rating on Regeneron Pharma (REGN)
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO reiterates Outperform on REGN; target $920; current price $741.41; price changed -0.12 since signal.
- Target $920; price $741.41; Outperform reiterated by BMO.
Key facts
- 01
Target: $920
- 02
Posted price: $741.41
- 03
Analyst firm: BMO Capital
- 04
Analyst: Evan David Seigerman
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.